Brief: Orchard Therapeutics Says Notified Ucl Business & Regents Of Ucla That Co Was Terminating License Relating Co's Otl-101 Program For Ada-Scid
28/05/2021 23:34
May 28 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS - CO NOTIFIED UCL BUSINESS & REGENTS
OF
UCLA THAT CO WAS TERMINATING LICENSE RELATING CO'S OTL-101
PROGRAM FOR ADA-SCID
Source text: [ID: https://bit.ly/3fPJYG4]
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln